Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
ISX:SDPC's PB Ratio is ranked better than 77.68% of 112
companies
in the Medical Distribution industry
Industry Median: 1
vs ISX:SDPC: 0.70
During the past 12 months, PT Millennium Pharmacon International Tbk's average Book Value Per Share Growth Rate was 11.20% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 6.80% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 6.50% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was 2.90% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of PT Millennium Pharmacon International Tbk was 8.70% per year. The lowest was -1.50% per year. And the median was 5.70% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
PT Millennium Pharmacon International Tbk PB Ratio Related Terms
PT Millennium Pharmacon International Tbk PB Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Millennium Pharmacon International Tbk PB Ratio Chart
PT Millennium Pharmacon International Tbk Annual Data
For the Medical Distribution subindustry, PT Millennium Pharmacon International Tbk's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PT Millennium Pharmacon International Tbk PB Ratio vs Medical Distribution Industry
PT Millennium Pharmacon International Tbk PB Ratio Calculation
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
PT Millennium Pharmacon International Tbk (ISX:SDPC) has a PB Ratio of 0.71 as of Aug. 01, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on PT Millennium Pharmacon International Tbk and its competitors. This is 18% above median its historical median of 0.60. Over the past decade, PT Millennium Pharmacon International Tbk's PB Ratio has ranged from 0.36 to 1.74. According to the industry distribution chart, PT Millennium Pharmacon International Tbk ranks #25 out of 112 companies in the Medical Distribution industry, placing it in the top 22.3%.
Is PT Millennium Pharmacon International Tbk's PB Ratio too high?
PT Millennium Pharmacon International Tbk's current PB Ratio of 0.71 is 18% above median its 10-year median of 0.60. Over the past 10 years, this metric has ranged from a low of 0.36 to a high of 1.74. The Medical Distribution industry median PB Ratio is 1.00. PT Millennium Pharmacon International Tbk's value of 0.71 is 29% below this industry median. Based on the distribution chart, PT Millennium Pharmacon International Tbk ranks #25 out of 112 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, PT Millennium Pharmacon International Tbk has a GF Score™ of 79/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does PT Millennium Pharmacon International Tbk's PB Ratio compare to MCK and COR?
According to the Medical Distribution industry distribution chart, PT Millennium Pharmacon International Tbk ranks #25 out of 112 companies for PB Ratio. This places PT Millennium Pharmacon International Tbk in the top 22% of its industry — outperforming the majority of peers. The industry median PB Ratio is 1.00. PT Millennium Pharmacon International Tbk's value of 0.71 is 29% below this benchmark. Historically, PT Millennium Pharmacon International Tbk's own PB Ratio has ranged from 0.36 to 1.74 over the past decade. While the company's 10-year median is 0.60 vs. the industry median of 1.00, PT Millennium Pharmacon International Tbk has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Medical Distribution company?
The median PB Ratio among Medical Distribution companies is 1.00, based on 112 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PT Millennium Pharmacon International Tbk's current PB Ratio of 0.71 is 29% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on PT Millennium Pharmacon International Tbk and its competitors. For the Medical Distribution industry, the median PB Ratio is 1.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Millennium Pharmacon International Tbk's current PB Ratio is 0.71, which is 18% above median its own 10-year median of 0.60. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Millennium Pharmacon International Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Millennium Pharmacon International Tbk (ISX:SDPC) is currently considered Fairly Valued. The stock's GF Value™ is Rp166.83, compared to a current price of Rp181.00 — trading 8.5% above its estimated fair value. The current PB Ratio is 0.71, which is 18% above median its 10-year median of 0.60 and 29% below the Medical Distribution industry median of 1.00. PT Millennium Pharmacon International Tbk's overall GF Score™ is 79/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For PT Millennium Pharmacon International Tbk (ISX:SDPC), the current PB Ratio is 0.71 as of Aug. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PT Millennium Pharmacon International Tbk (ISX:SDPC) Overvalued in 2026?
Based on GuruFocus' analysis, PT Millennium Pharmacon International Tbk stock appears to be overvalued.
The current stock price of Rp181.00 is trading 8.5% above its estimated GF Value™ of Rp166.83.
GuruFocus considers PT Millennium Pharmacon International Tbk to be Fairly Valued.
Key valuation signals for ISX:SDPC:
PB Ratio: 0.71 (18% above median its 10-year median of 0.60)
GF Value™: Rp166.83 vs. price of Rp181.00 (8.5% above fair value)
Industry Position: 29% below the Medical Distribution median (#25 of 112)
No single metric tells the full story. See the ISX:SDPC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
AddressJl. Sultan Iskandar Muda No 18/Jl. Bungur No. 1, Crown Bungur Arteri Lantai 2-4, Kel. Kebayoran Lama Selatan, Kec. Kebayoran Lama, South Jakarta, Jakarta, IDN, 12240
PT Millennium Pharmacon International Tbk is engaged in distributing medicines, food supplements, and medical disposables. The group's operating segments are Prescription medicine, Non-prescription medicine, Medical Disposables, and others, of which the majority of revenue is derived from the Prescription Medicine segment. The company's geographical segments are Jawa, Sumatra, Kalimantan, Sulawesi, and Bali & Lombok.
79GF Score
Get the complete analysis for ISX:SDPC
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:SDPC has been successfully added to your 
